Growing community of inventors

San Diego, CA, United States of America

Afton Hiscox

Average Co-Inventor Count = 9.08

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 90

Afton HiscoxMichael Anthony Letavic (6 patents)Afton HiscoxCurt A Dvorak (6 patents)Afton HiscoxChristine Fang Gelin (6 patents)Afton HiscoxBrice M Stenne (6 patents)Afton HiscoxChrista C Chrovian (5 patents)Afton HiscoxAkinola Soyode-Johnson (4 patents)Afton HiscoxJessica L Wall (4 patents)Afton HiscoxWei Zhang (3 patents)Afton HiscoxGang Chen (3 patents)Afton HiscoxHeather Renee Coate (3 patents)Afton HiscoxJason Christopher Rech (3 patents)Afton HiscoxAndrew V Samant (3 patents)Afton HiscoxAfton Hiscox (6 patents)Michael Anthony LetavicMichael Anthony Letavic (65 patents)Curt A DvorakCurt A Dvorak (49 patents)Christine Fang GelinChristine Fang Gelin (25 patents)Brice M StenneBrice M Stenne (23 patents)Christa C ChrovianChrista C Chrovian (23 patents)Akinola Soyode-JohnsonAkinola Soyode-Johnson (22 patents)Jessica L WallJessica L Wall (12 patents)Wei ZhangWei Zhang (208 patents)Gang ChenGang Chen (53 patents)Heather Renee CoateHeather Renee Coate (32 patents)Jason Christopher RechJason Christopher Rech (21 patents)Andrew V SamantAndrew V Samant (8 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Pharmaceutica Nv (6 from 2,078 patents)


6 patents:

1. 11618750 - Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators

2. 11530210 - Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulators

3. 11161846 - Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators

4. 10766880 - Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

5. 10233173 - Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

6. 10071988 - Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…